Insider Spends €3.2m Buying More Shares In Medicover

Potential Medicover AB (publ) (STO:MCOV B) shareholders may wish to note that the Chief Financial Officer, Anand Patel, recently bought kr3.2m worth of stock, paying kr231 for each share. We reckon that's a good sign, especially since the purchase boosted their holding by 151%.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Medicover Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when Chief Operating Officer for Diagnostic Services Staffan Ternstrom bought kr20m worth of shares at a price of kr206 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of kr235. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.

In the last twelve months insiders purchased 116.71k shares for kr25m. But they sold 24.30k shares for kr6.4m. In total, Medicover insiders bought more than they sold over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

View our latest analysis for Medicover

Medicover is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Medicover Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Medicover insiders own 11% of the company, currently worth about kr4.0b based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

What Might The Insider Transactions At Medicover Tell Us?

It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Medicover. Nice! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Medicover. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Medicover.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.